c-FLIPL is upregulated in human tumors [51,61], rendering tumor cells resistant to therapies and immune surveillance [62], Regulatory T cells or Tregs turn off immune responses and have been used for immunotherapies. This evidence concerns the gene CFLAR and neoplasm.